Patent ductus arteriosus screening: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Patent ductus arteriosus}} {{CMG}}; {{AE}} {{RG}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR Acco..." |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
There is | There is no routine screening guideline for patent ductus arteriosus screening, but if it diagnosed early, it can benefit preterm neonates. | ||
==Screening== | ==Screening== | ||
*Patent ductus arteriosus is often diagnosed pre-partum by ultrasonography.<ref name="HamrickHansmann2010">{{cite journal|last1=Hamrick|first1=S. E. G.|last2=Hansmann|first2=G.|title=Patent Ductus Arteriosus of the Preterm Infant|journal=PEDIATRICS|volume=125|issue=5|year=2010|pages=1020–1030|issn=0031-4005|doi=10.1542/peds.2009-3506}}</ref> | |||
*It can benefit extremely premature neonates by reducing short term mortality of those.<ref name="Clyman2000">{{cite journal|last1=Clyman|first1=Ronald I.|title=Ibuprofen and Patent Ductus Arteriosus|journal=New England Journal of Medicine|volume=343|issue=10|year=2000|pages=728–730|issn=0028-4793|doi=10.1056/NEJM200009073431009}}</ref> | |||
*Checking for PDA is not a routine screening and is often times a randome finding.<ref name="SosenkoFajardo2012">{{cite journal|last1=Sosenko|first1=Ilene R.S.|last2=Fajardo|first2=M. Florencia|last3=Claure|first3=Nelson|last4=Bancalari|first4=Eduardo|title=Timing of Patent Ductus Arteriosus Treatment and Respiratory Outcome in Premature Infants: A Double-Blind Randomized Controlled Trial|journal=The Journal of Pediatrics|volume=160|issue=6|year=2012|pages=929–935.e1|issn=00223476|doi=10.1016/j.jpeds.2011.12.031}}</ref> | |||
==References== | ==References== | ||
Revision as of 02:03, 18 February 2020
|
Patent Ductus Arteriosus Microchapters |
|
Differentiating Patent Ductus Arteriosus from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Medical Therapy |
|
Case Studies |
|
Patent ductus arteriosus screening On the Web |
|
American Roentgen Ray Society Images of Patent ductus arteriosus screening |
|
Risk calculators and risk factors for Patent ductus arteriosus screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
There is no routine screening guideline for patent ductus arteriosus screening, but if it diagnosed early, it can benefit preterm neonates.
Screening
- Patent ductus arteriosus is often diagnosed pre-partum by ultrasonography.[1]
- It can benefit extremely premature neonates by reducing short term mortality of those.[2]
- Checking for PDA is not a routine screening and is often times a randome finding.[3]
References
- ↑ Hamrick, S. E. G.; Hansmann, G. (2010). "Patent Ductus Arteriosus of the Preterm Infant". PEDIATRICS. 125 (5): 1020–1030. doi:10.1542/peds.2009-3506. ISSN 0031-4005.
- ↑ Clyman, Ronald I. (2000). "Ibuprofen and Patent Ductus Arteriosus". New England Journal of Medicine. 343 (10): 728–730. doi:10.1056/NEJM200009073431009. ISSN 0028-4793.
- ↑ Sosenko, Ilene R.S.; Fajardo, M. Florencia; Claure, Nelson; Bancalari, Eduardo (2012). "Timing of Patent Ductus Arteriosus Treatment and Respiratory Outcome in Premature Infants: A Double-Blind Randomized Controlled Trial". The Journal of Pediatrics. 160 (6): 929–935.e1. doi:10.1016/j.jpeds.2011.12.031. ISSN 0022-3476.